Domani Wealth, LLC Abb Vie Inc. Transaction History

Domani Wealth, LLC

$431 Million
Q1 2023

A detailed history of Domani Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Domani Wealth, LLC holds 3,051 shares of ABBV stock, worth $523,948. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,051

Previous 2,976 2.52%

Holding current value

$523,948

Previous $481,000 1.04%

% of portfolio

0.11%

Previous 0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $10,845 - $12,490	75 Added 2.52%	3,051 $486,000
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $97,785 - $117,270	-707 Reduced 19.2%	2,976 $0
Q1 2022 Apr 15, 2022	BUY	$131.98 - $163.75 $21,908 - $27,182	166 Added 4.72%	3,683 $597,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $11,709 - $14,816	109 Added 3.2%	3,517 $476,000
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 2.85%	3,408 $384,000
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $42,454 - $46,737	415 Added 13.42%	3,508 $380,000
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $40,245 - $54,335	-500 Reduced 13.92%	3,093 $331,000
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $31,700 - $37,206	369 Added 11.45%	3,593 $315,000
Q2 2020 Jul 24, 2020	SELL	$73.37 - $98.18 $11,739 - $15,708	-160 Reduced 4.73%	3,224 $317,000
Q1 2020 Apr 10, 2020	BUY	$64.5 - $97.79 $64,564 - $97,887	1,001 Added 42.01%	3,384 $258,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $171,885 - $215,065	2,383 New	2,383 $211,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Domani Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Domani Wealth, LLC with notifications on news.

Account

Domani Wealth, LLC Abb Vie Inc. Transaction History